Major Depression Inventory

Key Takeaways

The Major Depression Inventory is a 10-item self-report questionnaire that measures depression severity using ICD-10 and DSM-IV diagnostic criteria.

MDI scores range from 0-50; the Bech 2015 LEAD standardization bands are 0-20 (no or doubtful depression), 21-25 (mild), 26-30 (moderate), and 31-50 (severe).

MDI items directly map to clinical diagnostic criteria, making it valuable for structured assessment in primary care and psychiatric settings.

Pabau’s digital forms enable automated MDI delivery pre-appointment, response capture, and score logging directly into patient records for longitudinal outcome tracking.

Download your free Major Depression Inventory template

The Major Depression Inventory (MDI) is a short, clinically validated tool that helps mental health professionals systematically assess depression severity in adults. Developed by Per Bech at the WHO Collaborating Centre for Mental Health, the MDI measures the 10 core symptoms of a major depressive episode according to both ICD-10 and DSM-IV diagnostic frameworks.

As a result, that dual alignment makes it useful for practitioners who need a quick, evidence-based screening instrument that bridges international diagnostic standards.

What is the Major Depression Inventory (MDI)?

The Major Depression Inventory is a self-report questionnaire consisting of 10 items that assess depression symptoms experienced over the previous two weeks. Unlike clinician-administered tools, the MDI allows patients to complete the form independently, making it practical for busy clinical settings where time and resources are limited.

Notably, the tool’s design reflects the diagnostic logic of both the International Classification of Diseases, 10th Revision (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV).

Each item targets a specific symptom cluster: mood disturbance, guilt, sleep disruption, interest loss, concentration problems, energy levels, appetite changes, psychomotor symptoms, and suicide risk. In short, this targeted approach keeps the assessment comprehensive without excessive length.

Because it’s in the public domain and free to use, the Major Depression Inventory fits naturally into psychology practices, therapy practices, and psychiatry settings without licensing barriers. In fact, NHS Lothian and multiple academic centers use it routinely for screening and outcome measurement.

MDI items and the 10 questions

First, understanding the MDI’s structure is essential for proper administration and interpretation. Each of the 10 items targets a key diagnostic feature of major depressive disorder.

• Item 1: Depressed mood (sadness, emptiness, hopelessness)
• Item 2: Feelings of guilt or worthlessness
• Item 3: Sleep disturbance (insomnia or hypersomnia)
• Item 4: Loss of interest or pleasure (anhedonia)
• Item 5: Reduced concentration or indecisiveness
• Item 6: Fatigue or loss of energy
• Item 7: Changes in appetite (increased or decreased)
• Item 8: Psychomotor symptoms (agitation or retardation)
• Item 9: Reduced self-confidence or self-esteem
• Item 10: Suicidal ideation or thoughts of death

Each item uses a 0-5 response scale, reflecting symptom frequency and severity. Patients rate how often they experienced each symptom over the two-week assessment window, with anchors ranging from “not at all” (0) to “constantly” (5). This digital form structure maps directly to Pabau’s intake form engine, allowing practices to deploy the MDI as an automated pre-appointment questionnaire.

Major Depression Inventory scoring and interpretation

Scoring the Major Depression Inventory is straightforward: simply sum all 10 item responses (range 0-50). Overall, the total score directly translates to a depression severity category and clinical action.

Under the Bech 2015 LEAD standardization, a score of 21 or above is considered a probable indication of clinical depression according to both diagnostic systems. However, the MDI should never be used as a standalone diagnostic tool. It is a screening and severity-measurement instrument that must always be combined with clinical judgment and full diagnostic assessment.

ICD-10 and DSM-IV diagnostic alignment

One of the MDI’s primary strengths is its explicit alignment with diagnostic criteria. The International Classification of Diseases, 10th Revision (ICD-10) defines major depression based on the presence of depressed mood or anhedonia plus additional symptoms from a defined symptom list. The MDI’s 10 items directly map to these ICD-10 criteria, making the screening outcome clinically coherent across international settings and easy to pair with a broader mental state examination.

Similarly, the DSM-IV framework requires five or more symptoms from a specified list during a two-week period for a major depressive episode diagnosis. In addition, the MDI questionnaire covers all nine DSM-IV symptom clusters: mood, guilt, sleep, interest, concentration, fatigue, appetite, psychomotor changes, and suicidality.

This dual alignment supports psychiatry EMR workflows, where practitioners need clear documentation that ties assessment instruments back to formal diagnostic standards.

Clinical applications: Who should use the MDI?

The Major Depression Inventory is appropriate for use in multiple clinical settings:

• Primary care and general practice — routine screening for depression in patients presenting with mood concerns, fatigue, or physical symptoms suggestive of depression
• Psychiatric and mental health settings — baseline assessment at intake, progress monitoring during treatment, and outcome evaluation at discharge
• Therapy and counseling practices — used with therapy practice management tools to track client progress and demonstrate outcomes to referrers
• Research and population health — epidemiological screening and longitudinal outcome studies
• Occupational health and employee assistance programs — workplace mental health screening

The MDI’s brevity (10 items, 2-5 minutes completion time) and public-domain status make it especially practical for high-volume settings where clinician time is precious and licensing costs must be minimized.

Psychometric properties and clinical validity

The MDI has been extensively validated in peer-reviewed studies. Specifically, internal consistency (Cronbach’s alpha) typically ranges from 0.85 to 0.92, indicating that all 10 items measure a coherent construct. Likewise, test-retest reliability is robust, with correlations above 0.80 over short intervals.

Sensitivity and specificity for detecting major depressive disorder are both approximately 86% at the cutoff score of 26. In other words, the MDI correctly identifies about 86% of people with true depression (true-positive rate) and correctly rules out a similar proportion of people without depression (true-negative rate).

Compared to a clinician diagnostic interview, the MDI shows good concurrent validity, though as noted, it is not a replacement for comprehensive clinical assessment.

MDI vs PHQ-9, BDI-II, and Hamilton Rating Scale

Practitioners often wonder how the MDI compares to other widely-used depression measures. Here’s a brief comparison:

The MDI’s major advantage is its brevity combined with dual ICD-10/DSM-IV alignment. The PHQ-9, while equally brief and free, is more US-centric in its development. By comparison, the Beck Depression Inventory is longer and requires licensing, making it less practical for routine screening in resource-limited settings. The Hamilton Rating Scale (HAM-D) remains the gold standard in research but requires clinician training and administration time.

Known limitations of the Major Depression Inventory

While the MDI is a valuable tool, practitioners should be aware of its constraints:

• Self-report bias — patients may under-report symptoms due to stigma or over-report due to a desire for treatment
• Language and cultural considerations — the MDI was developed in Denmark and validated primarily in European and North American populations; translation validity and cultural applicability vary
• Lack of DSM-5 alignment — the MDI was designed around DSM-IV criteria; DSM-5 introduced modifications to the diagnostic criteria that the MDI does not explicitly capture
• Not a diagnostic instrument — the MDI is a screening and severity-measurement tool, never a substitute for comprehensive clinical evaluation
• Suicide item limitations — Item 10 captures presence of suicidal ideation but does not assess intent or plan; additional suicide-risk assessment is always required

How to streamline MDI administration in your practice with Pabau

Manual paper-based MDI administration creates friction in modern practices. Pabau’s digital forms module lets practices deploy the MDI as an automated pre-appointment intake form, sent via email or SMS link to patients before their appointment. Consequently, responses populate the patient record automatically, eliminating manual data entry and ensuring scores are logged longitudinally for outcome tracking.

Clinicians can set conditional logic to flag high-severity scores (e.g., MDI ≥31) in the appointment dashboard, prompting immediate clinical review before the session begins.

Pabau Scribe, our AI scribe, integrates MDI responses into automated clinical note generation, translating patient responses into structured psychotherapy progress notes that map directly to your EMR and reduce administrative burden on clinicians.

Limitations and when to use additional screening tools

The MDI covers core depression symptoms but does not assess comorbid anxiety. Practitioners managing complex psychiatric presentations often combine the MDI with the Beck Anxiety Inventory or a GAD-7 assessment template for comprehensive mood and anxiety assessment. For geriatric populations, the Geriatric Depression Scale may be more appropriate due to age-specific symptom presentation and somatic focus differences.

Additionally, baseline and longitudinal MDI scores provide valuable data for monitoring treatment response. Repeat assessments at 4-6 week intervals during treatment help clinicians evaluate whether a given therapeutic approach (medication, psychotherapy, lifestyle intervention) is producing measurable symptom improvement.

Conclusion

The Major Depression Inventory is a time-efficient, evidence-based screening tool that bridges international diagnostic standards and delivers meaningful clinical data in under five minutes. Ultimately, its public-domain status and dual ICD-10/DSM-IV alignment make it ideal for psychiatry and mental health practices seeking structured, validated assessment.

By integrating the MDI into your clinical workflow via Pabau’s digital forms, you reduce administrative friction while keeping longitudinal symptom tracking and treatment decisions well-informed.

Frequently asked questions about the MDI